CARDIAC RESYNCHRONIZATION THERAPY OPTIMIZATION USING ELECTROMECHANICAL DELAY FROM REALTIME ELECTRODE MOTION TRACKING

• US 20090306732A1
• Filed: 04/01/2009
• Published: 12/10/2009
• Est. Priority Date: 06/09/2008
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Noren, Kjell, Rosenberg, Stuart, Yang, Michael, Hou, Wenbo, Ryu, Kyungmoo, Keel, Allen, Nguyen, Thao Thu
• Granted Patent: US 8,019,409 B2
• Time in Patent Office: Days
• US Class Current: 607/9
• CPC Class Codes: A61B 2562/043 in a linear array
• CPC Class Codes: A61B 5/1107 Measuring contraction of parts of the body, e.g. organ, muscle apparatus for measuring work or force in general G01L
• CPC Class Codes: A61B 5/287 Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
• CPC Class Codes: A61B 5/349 Detecting specific parameters of the electrocardiograph cycle
• CPC Class Codes: A61B 5/6876 Blood vessel
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/36514 controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by two or more physical parameters A61N1/36585
• CPC Class Codes: A61N 1/36578 controlled by mechanical motion of the heart wall, e.g. measured by an accelerometer or microphone
• CPC Class Codes: A61N 1/3684 for stimulating the heart at multiple sites of the ventricle or the atrium
• CPC Class Codes: A61N 1/36842 Multi-site stimulation in the same chamber
• CPC Class Codes: A61N 1/36843 Bi-ventricular stimulation

Abstract

An exemplary method includes providing a mechanical activation time (MA time) for a myocardial location, the location defined at least in part by an electrode and the mechanical activation time determined at least in part by movement of the electrode; providing an electrical activation time (EA time) for the myocardial location; and determining an electromechanical delay (EMD) for the myocardial location based on the difference between the mechanical activation time (MA time) and the electrical activation time (EA time).

Claims

1. A method comprising:

providing a mechanical activation time (MA time) for a myocardial location, the location defined at least in part by an electrode, and the mechanical activation time determined at least in part by movement of the electrode, wherein the mechanical activation time comprises a time determined based on position data for the electrode wherein the electrode measures potential in a current field;

providing an electrical activation time (EA time) for the myocardial location wherein the electrical activation time comprises a time determined by electrical cardiac activity data acquired using the electrode over at least a portion of a cardiac cycle; and

determining an electromechanical delay (EMD) for the myocardial location based on a difference between the mechanical activation time (MA time) and the electrical activation time (EA time).

2. The method of claim 1 wherein the mechanical activation time and the electrical activation time are provided based on information acquired during a single cardiac cycle.

3. The method of claim 2 wherein the information comprises electrical information acquired at a first sampling rate and mechanical information acquired at a second sampling rate.

4. The method of claim 1 wherein the mechanical activation time and the electrical activation time are provided based on information acquired during multiple cardiac cycles.

5. The method of claim 4 wherein the information comprises electrical information acquired for a cardiac cycle and mechanical information acquired for a subsequent cardiac cycle or vice versa.

6. The method of claim 1 further comprising selecting one or more parameters for delivery of cardiac pacing therapy based at least in part on the determined electromechanical delay, wherein the one or more parameters are selected from a group consisting of electrode location, electrode polarity, number of electrodes, timing of stimulation, delay between delivery of stimuli, stimulation energy, stimulation duration, and stimulation polarity.

7. The method of claim 1 further comprising diagnosing a cardiac condition based at least in part on the determined electromechanical delay.

8. The method of claim 1 wherein the MA time is determined at a peak amplitude or a threshold amplitude of a displacement vector, representing instantaneous location of the electrode, with reference to location of the electrode at the EA time.

9. The method of claim 1 wherein the MA time is determined at a peak amplitude or a threshold amplitude of instantaneous velocity of the electrode, the instantaneous velocity derived from instantaneous location of the electrode at consecutive sample points in time.

10. The method of claim 1 wherein the MA time is determined at a peak amplitude or a threshold amplitude of a rate of change of distance of instantaneous location of the electrode, with reference to the location of the electrode at the EA time.

11. The method of claim 1 wherein the MA time is determined at a zero instantaneous velocity or a sub-threshold amplitude of position change at consecutive sample points, corresponding to a physiologic pause in a cardiac cycle.

12. The method of claim 1 wherein determination of the electromechanical delay comprises triggering acquisition of mechanical information using the electrode based at least in part on detection of an EA time local to the electrode, the mechanical information sufficient to determine the MA time.

13. The method of claim 1 further comprising determining mechanical latency as a time interval from a time of onset of a Q-wave in a surface ECG (global EA time) to a time of mechanical activation (MA time), determining electrical latency as a time interval from a time of onset of a Q-wave in a surface ECG to a time of local electrical activation (local EA time) in a IEGM, and determining the electromechanical delay (EMD) as a difference between the determined mechanical latency and the determined electrical latency.

14. The method of claims 1 further comprising determining mechanical latency as a time interval from a time of first deflection of an intracardiac far-field ventricular potential to a time of mechanical activation (MA time), determining a local electrical latency as a time interval from a time of first deflection of an intracardiac far-field ventricular potential to a time of electrical activation (EA time) in an IEGM, and determining the electromechanical delay (EMD) as a difference between the determined mechanical latency and the determined electrical latency.

15. The method of claim 1 further comprising determining a local electromechanical delay for each of a plurality of implanted electrodes.

16. The method of claim 15 further comprising presenting graphically each of the electromechanical delays along with respective anatomic locations, mapped on an image of the heart, to thereby yield a map tool to guide CRT lead placement.

17. The method of claim 15 further comprising:

comparing the local electromechanical delays; and

visually or audibly identifying the implanted electrode having the shortest local electromechanical delay as the optimal therapy delivering electrode.

18. The method of claim 1 further comprising aggregating individually determined electromechanical delays from a plurality of implanted electrodes and determining statistics for the electromechanical delays to provide a global electromechanical delay index.

19. The method of claim 1 wherein the electromechanical delay is determined based on recorded cardiac electrograms and recorded positions of one or more electrodes with respect to time during one or more cardiac cycles, wherein the recorded positions comprise recorded positions for respective locations of the one or more electrode, the respective locations due to maneuvering of the one or more electrodes within a cardiac space.

20. The method of claim 19 further comprising generating an electromechanical delay map or index after recording positions for two or more locations.

21. The method of claim 1 wherein the electromechanical delay is determined based on recorded cardiac electrograms and recorded positions of one or more electrodes with respect to time during one or more cardiac cycles, wherein the recorded positions comprise recorded positions taken at various fixed locations as one or more additional electrodes are maneuvered within the cardiac space.

22. The method of claim 21 further comprising providing pacing at different locations and generating a separate electromechanical index or map for each respective pacing location.

23. The method of claim 1 further comprising defining a region by specific locations of each of a plurality of electrodes in a cardiac space and determining an electromechanical delay for the region.

24. The method of claim 1 further comprising defining a representative vector or cardiac axis by specific locations of each of a plurality of electrodes in a cardiac space and defining a global mechanical latency as a time interval from an electrical activity time trigger to a time of minimum vector or axis length or peak vector or axis shortening velocity.

25. The method of claim 1 wherein onset of motion of the electrode, after detection of a T-wave, indicates beginning of diastolic relaxation.

26. The method of claim 1 wherein onset of motion of an electrode located in the right atrium indicates beginning of active diastolic filling.

27. The method of claim 1 wherein times of onset of motion of various electrodes, with respect to associated cardiac electrograms, delineate phases of a cardiac cycle.

28. The method of claim 27 further comprising determining indices of global cardiac function based in part on durations of the various phases of a cardiac cycle.

29. A system comprising:

one or more processors;

memory; and

control logic, implemented at least in part by the one or more processors and the memory, configured to;

determine a mechanical activation time (MA time) for a myocardial location, the location defined at least in part by an electrode, and the mechanical activation time (MA time) determined at least in part by movement of the electrode, wherein the mechanical activation time comprises a time determined based on position data for the electrode wherein the electrode measures potential in a current field;

determine an electrical activation time (EA time) for the myocardial location wherein the electrical activation time (EA time) comprises a time determined by electrical cardiac activity data acquired using the electrode over at least a portion of a cardiac cycle; and

determine an electromechanical delay (EMD) for the myocardial location based on a difference between the mechanical activation time (MA time) and the electrical activation time (EA time).

30. The system of claim 29 further comprising a display, wherein:

the control logic is further configured to determine a local electromechanical delay for each of a plurality of implanted electrodes; and

the display is operative to present graphically each of the electromechanical delays along with respective anatomic locations, mapped on an image of the heart, to thereby yield a map tool to guide CRT lead placement.

31. The system of claim 29 further comprising a user interface, wherein:

the control logic is further configured to determine a local electromechanical delay for each of a plurality of implanted electrodes and compare the local electromechanical delays; and

the user interface is operative to visually or audibly identify the implanted electrode having the shortest local electromechanical delay as the optimal therapy delivering electrode.